Deutsche Bank
MRTX

Deutsche Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Deutsche Bank’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-115,976
Closed -$6.81M – 3718
2023
Q4 		$6.81M Sell
115,976
-126,585
-52% -$7.12M ﹤0.01% 1134
2023
Q3 		$10.6M Buy
242,561
+7,032
+3% +$251K 0.01% 852
2023
Q2 		$8.51M Sell
235,529
-3,326
-1% -$137K ﹤0.01% 1034
2023
Q1 		$8.88M Buy
238,855
+11,534
+5% +$519K ﹤0.01% 1012
2022
Q4 		$10.3M Buy
227,321
+24,688
+12% +$1.6M 0.01% 952
2022
Q3 		$14.2M Sell
202,633
-30,119
-13% -$2.23M 0.01% 854
2022
Q2 		$15.6M Buy
232,752
+9,429
+4% +$600K 0.01% 850
2022
Q1 		$18.4M Buy
223,323
+3,983
+2% +$407K 0.01% 861
2021
Q4 		$32.2M Sell
219,340
-340,348
-61% -$52.8M 0.01% 722
2021
Q3 		$99M Sell
559,688
-1,344
-0.2% -$216K 0.05% 369
2021
Q2 		$90.6M Buy
561,032
+333,765
+147% +$53.6M 0.04% 414
2021
Q1 		$38.9M Sell
227,267
-31,381
-12% -$6.21M 0.02% 667
2020
Q4 		$56.8M Buy
258,648
+135,642
+110% +$29.3M 0.03% 461
2020
Q3 		$20.4M Sell
123,006
-40,112
-25% -$5.49M 0.01% 695
2020
Q2 		$18.6M Sell
163,118
-67,569
-29% -$6.55M 0.01% 713
2020
Q1 		$17.7M Sell
230,687
-14,676
-6% -$1.32M 0.02% 687
2019
Q4 		$31.6M Buy
245,363
+161,127
+191% +$15.5M 0.02% 616
2019
Q3 		$6.56M Sell
84,236
-237,971
-74% -$22.3M ﹤0.01% 1245
2019
Q2 		$33.2M Buy
322,207
+250,442
+349% +$19.5M 0.02% 746
2019
Q1 		$5.26M Sell
71,765
-17,308
-19% -$1.18M ﹤0.01% 1845
2018
Q4 		$3.78M Sell
89,073
-155,774
-64% -$6.21M ﹤0.01% 1977
2018
Q3 		$11.5M Buy
244,847
+139,521
+132% +$7.77M 0.01% 1530
2018
Q2 		$5.19M Sell
105,326
-34,444
-25% -$1.3M ﹤0.01% 2275
2018
Q1 		$4.29M Buy
139,770
+138,113
+8,335% +$3.83M ﹤0.01% 2347
2017
Q4 		$30K Sell
1,657
-14,888
-90% -$231K ﹤0.01% 4580
2017
Q3 		$193K Hold
16,545
– – ﹤0.01% 3902
2017
Q2 		$60K Sell
16,545
-33,779
-67% -$129K ﹤0.01% 4334
2017
Q1 		$260K Buy
50,324
+17,488
+53% +$95.8K ﹤0.01% 3445
2016
Q4 		$155K Sell
32,836
-86,396
-72% -$470K ﹤0.01% 3830
2016
Q3 		$787K Sell
119,232
-165,286
-58% -$880K ﹤0.01% 2973
2016
Q2 		$1.55M Buy
284,518
+100,276
+54% +$1.6M ﹤0.01% 2587
2016
Q1 		$3.94M Sell
184,242
-1,105
-0.6% -$24.7K ﹤0.01% 1900
2015
Q4 		$5.86M Sell
185,347
-671
-0.4% -$23.7K ﹤0.01% 1691
2015
Q3 		$6.4M Buy
186,018
+181,125
+3,702% +$5.48M ﹤0.01% 1614
2015
Q2 		$153K Sell
4,893
-22,640
-82% -$667K ﹤0.01% 4014
2015
Q1 		$806K Buy
27,533
+7,429
+37% +$174K ﹤0.01% 3003
2014
Q4 		$372K Sell
20,104
-67
-0.3% -$1.13K ﹤0.01% 3881
2014
Q3 		$353K Sell
20,171
-164
-0.8% -$3.06K ﹤0.01% 3727
2014
Q2 		$406K Sell
20,335
-1,043
-5% -$20.1K ﹤0.01% 3617
2014
Q1 		$406K Buy
21,378
+772
+4% +$16K ﹤0.01% 3470
2013
Q4 		$342K Sell
20,606
-8,021
-28% -$137K ﹤0.01% 3357
2013
Q3 		$432K Buy
+28,627
New +$281K ﹤0.01% 3616

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deutsche Bank's MRTX Position: Q1 2024 in Review

Deutsche Bank sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 115,976 shares — an estimated $6.81M sold.

Deutsche Bank first reported a position in MRTX in Q3 2013 and held it in 42 quarters. The position peaked at $99M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Deutsche Bank reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 115,976 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.81M.
  • Deutsche Bank first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2013 and held it in 42 quarters.
  • Deutsche Bank's Mirati Therapeutics, Inc. Common Stock position peaked at $99M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.